Cytek BioSciences Inc (NASDAQ:CTKB) shares, rose in value, with the stock price down by -0.54% to the previous day’s close as strong demand from buyers drove the stock to $3.65.
Actively observing the price movement in the last trading, the stock closed the session at $3.67, falling within a range of $3.4746 and $3.6787. The value of beta (5-year monthly) was 1.413. Referring to stock’s 52-week performance, its high was $7.63, and the low was $3.27. On the whole, CTKB has fluctuated by -13.51% over the past month.
With the market capitalization of Cytek BioSciences Inc currently standing at about $467.56 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 204.43M, with a low estimate of 39.9M and a high estimate of 44.73M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 42.66M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CTKB’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CTKB currently trading nearly -5.02% and -16.88% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.95, while the 7-day volatility ratio is showing 4.79% which for the 30-day chart, stands at 6.37%. Furthermore, Cytek BioSciences Inc (CTKB)’s beta value is 1.39, and its average true range (ATR) is 0.24.
A comparison of Cytek BioSciences Inc (CTKB) with its peers suggests the former has fared considerably weaker in the market. CTKB showed an intraday change of -0.54% in last session, and over the past year, it shrunk by -38.86%%.
Data on historical trading for Cytek BioSciences Inc (NASDAQ:CTKB) indicates that the trading volumes over the past 10 days have averaged 0.78 and over the past 3 months, they’ve averaged 844.17K. According to company’s latest data on outstanding shares, there are 129.21 million shares outstanding.
Nearly 9.37% of Cytek BioSciences Inc’s shares belong to company insiders and institutional investors own 60.14% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.53 million shares as on 2025-03-31, resulting in a short ratio of 4.73. According to the data, the short interest in Cytek BioSciences Inc (CTKB) stood at 457.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 3.45 million. The stock has fallen by -43.76% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CTKB stock heading into the next quarter.
